β-Thalassemia is a genetic disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin, leading to ineffective erythropoiesis and severe anemia. Patients with ...
Hemochromatosis is a condition that causes an overload of iron in the blood. Many people do not show any symptoms, but some experience fatigue and joint pain. It can either be inherited or caused by ...
Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...
Saturation of TfR1 leads to the dissociation of Hfe and the binding of the alter to the TfR2, which in turn influences the binding of BMP6 to its receptors on the membrane. Increased liver iron ...
FDA approval of mitapivat signals a shift in thalassaemia care, offering the first oral option to treat chronic anaemia.
NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative ...
Transfusion-dependent β-thalassemia (TDT) patients in France face significant health care demands and clinical challenges, with frequent complications and high mortality rates. Patients with TDT ...
MedPage Today on MSN
FDA Approves First Oral Medication for Iron Deficiency in Kids
The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...
"Study suggests preoperative iron infusions work better than blood transfusions for some anemic patients." ScienceDaily. www.sciencedaily.com / releases / 2024 / 07 / 240725154706.htm (accessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback